Loading clinical trials...

Effect of Mizagliflozin Repeat Dosing on Adverse Events and Postprandial Glucose Excursions | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 2NCT05721729

Effect of Mizagliflozin Repeat Dosing on Adverse Events and Postprandial Glucose Excursions

This is a phase 2 crossover, randomized, placebo-controlled, single-blind, repeat dose study in PBH subjects to determine the effect of mizagliflozin on adverse events and postprandial glucose excursi...

Lead sponsor: Vogenx, Inc.•2 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

COMPLETEDPhase 2

Safety and Efficacy of Exendin 9-39 in Patients With Postbariatric Hypoglycemia

NCT03373435 · Postbariatric Hypoglycemia

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 18, 2025Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment15

Start dateJun 2023

Last updatedDec 18, 2025

Condition

Postbariatric Hypoglycemia

Locations shown

Stanford

Palo Alto, California

University of Colorado / Anschutz Medical Campus

Aurora, Colorado

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 18, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions